000 02240nam a22003378i 4500
001 CR9780511629419
003 UkCbUP
005 20200124160310.0
006 m|||||o||d||||||||
007 cr||||||||||||
008 090918s2002||||enk o ||1 0|eng|d
020 _a9780511629419 (ebook)
020 _z9780521771108 (hardback)
040 _aUkCbUP
_beng
_erda
_cUkCbUP
050 0 0 _aRC372.5
_b.E623 2002
082 0 0 _a616.8/53
_221
245 0 0 _aEpilepsy and movement disorders /
_cedited by Renzo Guerrini [and others].
246 3 _aEpilepsy & Movement Disorders
264 1 _aCambridge :
_bCambridge University Press,
_c2002.
300 _a1 online resource (xxvii, 557 pages) :
_bdigital, PDF file(s).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aTitle from publisher's bibliographic system (viewed on 05 Oct 2015).
520 _aThe boundaries between epilepsy and movement disorders are difficult to define; some syndromes or diseases may combine the two and many manifestations of one are similar to the other. For the first time, a distinguished, international team of specialists comprehensively examines the clinical, neurophysiological, genetic, pharmacological and molecular factors which underlie the relationships and differences between the two disorders. They examine the methods for investigating motor cortex excitability and the electrophysiological and chemical characteristics of epilepsies which resemble movement disorders. They present a scheme for neurophysiological classification of myoclonic epilepsies and myoclonus and give a detailed analysis of the disorders which cause diagnostic problems in children and adults. There is also an innovative, up-to-date review of the genetic syndromes which associate epilepsy and paroxysmal dyskinesias, and a review of the drugs used to treat, or which may precipitate, epilepsy and movement disorders. This is essential reading for clinicians and neuroscientists.
650 0 _aEpilepsy.
650 0 _aMovement disorders.
700 1 _aGuerrini, Renzo,
_eeditor.
776 0 8 _iPrint version:
_z9780521771108
856 4 0 _uhttps://doi.org/10.1017/CBO9780511629419
999 _c520990
_d520988